Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 83.47

-1.7%

Feb 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Perry who wrote (1878)	4/3/1998 10:54:00 AM
From: SG	Read Replies (1) of 4676

CNTO's drug Avakine will hopefully (for us Crohn's people, not for ISIP investors) be approved May, 1998 on "quick review " or some other euphemism. I can tell you that CD people are waiting at the gates and that getting there first is half the battle. 2302 would have to be better, fewer side effects, cheaper, or more readily distributed if they aren't fast. SG

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next